
Carla Grandori, MD, PhD Founder and CEO of SEngine Precision Medicine
-
June 30, 2023
PARIS Test Uses Lab-Grown Mini-Tumors to Find a Patient’s Best Treatment
With:The U.S. Food and Drug Administration (FDA) has approved hundreds of drugs for the treatment of cancer. However, some approved drugs are more effective for certain patients than others. Our curious Dr. George asks Carla Grandori, MD, PhD, Founder and CEO of SEngine Precision Medicine, about her company’s test to detect which drugs are likely to be most effective for a given patient’s solid tumor.… Read more »